Global Burden of Drug Use Disorders by Region and Country, 1990-2021

Overview

Journal Front Public Health

Specialty Public Health

Date 2024 Nov 13

PMID 39534741

Authors

Shuyan Zhang

Xiaoying Qi

Yingying Wang

Keyuan Fang

Affiliations

Soon will be listed here.

Abstract

Background: This study used data from the Global Burden of Disease Study (GBD) database to systematically assess the magnitude of drug use disorders (DUD) burden between 1990 and 2021.

Methods: This study used GBD data to analyze the trends in ASIR, DALYs and other DUD indicators from 1990 to 2021, and compared them among different regions and countries. The Estimated Annual Percentage Change (EAPC) and its 95% Confidence Interval (CI) were calculated to assess the temporal and geographical disparities. ASIR and DALYs were used to evaluate the burden of DUDs, and socio-demographic index (SDI) was used to measure the socio-economic development level of each country.

Results: The global ASIR of DUDs showed a slight downward trend (EAPC = -0.26). The age-standardized DALY rate (per 100,000) significantly declined from 1990 to 2021 (EAPC = -1.44). Among the regions, the high SDI region exhibited the most substantial increase in ASIR (EAPC = 0.65). On a regional level, the high-income North America region had the highest EAPC for both age-standardized DALYs and ASIR (EAPC = 4.82, 1.02, respectively). Nationally, the United States of America reported the largest increase in age-standardized DALY rates and EAPC for ASIR (EAPC of 4.88, 1.05, respectively), while South Africa had the most significant decrease in EAPC (EAPC of -3.62, -1.52, respectively). In 2021, the highest ASIR was observed in high-income North America at 520.07; Central Asia had the highest age-standardized DALY rate. Globally, age-standardized DALYs and ASIR for DUDs were generally higher in men than in women, and the burden of DUDs decreased with age.

Conclusion: The global burden of DUDs has shown complex and changing trends over the last decades, with large differences in burden between regions and countries. This highlights the need for targeted public health policies and interventions in High income North America region and Eastern Europe.

References

Nutt D, King L, Saulsbury W, Blakemore C . Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007; 369(9566):1047-53. DOI: 10.1016/S0140-6736(07)60464-4. View

Whiteford H, Degenhardt L, Rehm J, Baxter A, Ferrari A, Erskine H . Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382(9904):1575-86. DOI: 10.1016/S0140-6736(13)61611-6. View

Shen J, Hua G, Li C, Liu S, Liu L, Jiao J . Prevalence, incidence, deaths, and disability-adjusted life-years of drug use disorders for 204 countries and territories during the past 30 years. Asian J Psychiatr. 2023; 86:103677. DOI: 10.1016/j.ajp.2023.103677. View

Fogo R, Martins-da-Silva A, Blaas I, Pequeno Galvao L, Hasegawa E, Castaldelli F . Exploring correlates of involuntary treatment in substance use disorders: a global systematic review and meta-analysis. Int Rev Psychiatry. 2024; 35(5-6):418-433. DOI: 10.1080/09540261.2023.2228921. View

Compton W, Volkow N . Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2005; 81(2):103-7. DOI: 10.1016/j.drugalcdep.2005.05.009. View

Pan Z, Zhang J, Cheng H, Bu Q, Li N, Deng Y . Trends of the incidence of drug use disorders from 1990 to 2017: an analysis based on the Global Burden of Disease 2017 data. Epidemiol Psychiatr Sci. 2020; 29:e148. PMC: 7443796. DOI: 10.1017/S2045796020000657. View

Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J . Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018; 113(10):1905-1926. DOI: 10.1111/add.14234. View

. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2162-2203. PMC: 11120204. DOI: 10.1016/S0140-6736(24)00933-4. View

. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global.... Lancet. 2024; 403(10440):1989-2056. PMC: 11126395. DOI: 10.1016/S0140-6736(24)00476-8. View

10.

Ghimire B, Suguimoto S, Zamani S, Ono-Kihara M, Kihara M . Vulnerability to HIV infection among female drug users in Kathmandu Valley, Nepal: a cross-sectional study. BMC Public Health. 2013; 13:1238. PMC: 3908481. DOI: 10.1186/1471-2458-13-1238. View

11.

Camchong J, Lim K, Kumra S . Adverse Effects of Cannabis on Adolescent Brain Development: A Longitudinal Study. Cereb Cortex. 2016; 27(3):1922-1930. PMC: 5963818. DOI: 10.1093/cercor/bhw015. View

12.

Compton 3rd W, Cottler L, Jacobs J, Ben-Abdallah A, Spitznagel E . The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003; 160(5):890-5. DOI: 10.1176/appi.ajp.160.5.890. View

13.

Tyndale R . Drug addiction: a critical problem calling for novel solutions. Clin Pharmacol Ther. 2008; 83(4):503-6. DOI: 10.1038/clpt.2008.11. View

14.

. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

15.

Zhang T, Chen H, Yin X, He Q, Man J, Yang X . Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study. Chin J Cancer Res. 2021; 33(1):11-26. PMC: 7941685. DOI: 10.21147/j.issn.1000-9604.2021.01.02. View

16.

. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2100-2132. PMC: 11126520. DOI: 10.1016/S0140-6736(24)00367-2. View

17.

Wilcox H, Conner K, Caine E . Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend. 2004; 76 Suppl:S11-9. DOI: 10.1016/j.drugalcdep.2004.08.003. View

18.

Lin S, Lei S, Liu W, Zhu X, Yin L, Liu Q . Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study. Int J Clin Pharm. 2024; 46(5):1076-1090. DOI: 10.1007/s11096-024-01738-6. View

19.

Zhang T, Yin X, Chen H, Li Y, Chen J, Yang X . Global magnitude and temporal trends of idiopathic developmental intellectual disability attributable to lead exposure from 1990 to 2019: Results from Global Burden of Disease Study. Sci Total Environ. 2022; 834:155366. DOI: 10.1016/j.scitotenv.2022.155366. View

20.

. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1160-1203. PMC: 7566045. DOI: 10.1016/S0140-6736(20)30977-6. View